Medios AG (0QB4.L)
EUR 11.72
(3.72%)
EUR 11.72
(3.72%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 17.14 Million EUR | -2.75% |
| 2022 | 17.63 Million EUR | -64.53% |
| 2021 | 49.71 Million EUR | 158.56% |
| 2020 | 19.22 Million EUR | 208.05% |
| 2019 | 6.24 Million EUR | 2971.96% |
| 2018 | 203.16 Thousand EUR | 0.0% |
| 2017 | - EUR | 0.0% |
| 2016 | - EUR | 0.0% |
| 2015 | - EUR | 0.0% |
| 2014 | - EUR | 0.0% |
| 2013 | - EUR | 0.0% |
| 2012 | - EUR | -100.0% |
| 2011 | 128.87 Thousand EUR | -49.15% |
| 2010 | 253.45 Thousand EUR | -0.99% |
| 2009 | 256 Thousand EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 238.46 Million EUR | 1300.51% |
| 2024 Q1 | 17.02 Million EUR | -0.71% |
| 2023 Q2 | 64.53 Million EUR | 41.12% |
| 2023 Q3 | 20.15 Million EUR | -68.77% |
| 2023 FY | 17.14 Million EUR | -2.75% |
| 2023 Q4 | 17.14 Million EUR | -14.92% |
| 2023 Q1 | 45.73 Million EUR | 159.34% |
| 2022 Q4 | 17.63 Million EUR | -18.58% |
| 2022 Q2 | 43.54 Million EUR | 137.33% |
| 2022 FY | 17.63 Million EUR | -64.53% |
| 2022 Q1 | 18.34 Million EUR | -63.09% |
| 2022 Q3 | 21.65 Million EUR | -50.27% |
| 2021 Q1 | 53.38 Million EUR | 177.69% |
| 2021 Q3 | 52.75 Million EUR | -0.61% |
| 2021 Q4 | 49.71 Million EUR | -5.77% |
| 2021 FY | 49.71 Million EUR | 158.56% |
| 2021 Q2 | 53.07 Million EUR | -0.58% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 19.22 Million EUR | 208.05% |
| 2020 Q4 | 19.22 Million EUR | 146.05% |
| 2020 Q3 | 7.81 Million EUR | -58.55% |
| 2020 Q2 | 18.85 Million EUR | 0.0% |
| 2019 Q4 | 6.24 Million EUR | 0.0% |
| 2019 FY | 6.24 Million EUR | 2971.96% |
| 2019 Q2 | 2.08 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2018 Q1 | - EUR | 0.0% |
| 2018 FY | 203.16 Thousand EUR | 0.0% |
| 2018 Q4 | 203.16 Thousand EUR | 0.0% |
| 2018 Q3 | 203.16 Thousand EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2017 Q4 | - EUR | 0.0% |
| 2017 Q3 | - EUR | 0.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2017 Q1 | - EUR | 0.0% |
| 2017 FY | - EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 Q1 | - EUR | 0.0% |
| 2016 FY | - EUR | 0.0% |
| 2016 Q4 | - EUR | 0.0% |
| 2016 Q3 | - EUR | 0.0% |
| 2015 Q4 | - EUR | 0.0% |
| 2015 FY | - EUR | 0.0% |
| 2015 Q2 | - EUR | 0.0% |
| 2014 Q4 | - EUR | 0.0% |
| 2014 FY | - EUR | 0.0% |
| 2014 Q2 | - EUR | 0.0% |
| 2013 Q2 | 5000.00 EUR | 0.0% |
| 2013 Q4 | - EUR | 0.0% |
| 2013 FY | - EUR | 0.0% |
| 2012 Q2 | 112 Thousand EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 FY | - EUR | -100.0% |
| 2011 FY | 128.87 Thousand EUR | -49.15% |
| 2011 Q4 | 128.87 Thousand EUR | 0.0% |
| 2011 Q2 | 140 Thousand EUR | 0.0% |
| 2010 Q4 | 253.45 Thousand EUR | 0.0% |
| 2010 FY | 253.45 Thousand EUR | -0.99% |
| 2010 Q2 | 253 Thousand EUR | 0.0% |
| 2009 Q4 | 256 Thousand EUR | 0.0% |
| 2009 FY | 256 Thousand EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Cegedim SA | 285.1 Million EUR | 93.985% |
| Guerbet SA | 364.58 Million EUR | 95.297% |
| Nexus AG | 20.24 Million EUR | 15.298% |
| Bastide Le Confort Médical SA | 356.96 Million EUR | 95.196% |
| Revenio Group Oyj | 18.7 Million EUR | 8.299% |
| Drägerwerk AG & Co. KGaA | 471.38 Million EUR | 96.362% |
| Sartorius Aktiengesellschaft | 5.27 Billion EUR | 99.675% |
| LNA Santé SA | 887.67 Million EUR | 98.068% |
| Siemens Healthineers AG | 633 Million EUR | 97.291% |
| Equasens Société anonyme | 69.27 Million EUR | 75.246% |
| Stratec SE | 141.37 Million EUR | 87.87% |